GenScript Biotech

US/Netherlands-based biotech (HKSE: 1548.HK). Provides custom peptide synthesis, gene synthesis, CRISPR services, and protein expression. ISO 9001 and ISO 13485 certified. Operates cGMP peptide facility launched 2023. Serves 100,000+ researchers globally with verified international shipping to most major research hubs.

GenScript Biotech is listed as a CDMO in the peptide supply chain, serving Global markets from USA / China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 3 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.